Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System
ODW is the FDA product code for Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System, a class II device type, regulated under 21 CFR 862.3360. FDA's definition for this code reads: "An in vitro diagnostic assay for use in genotyping Cytochrome P450 2C9 (CYP450 2C9) alleles. Information about the CYP2C9 genotype may be used as an aid to clinicians in determining therapeutic strategy for medications that are metabolized by the CYP2C9 gene product". As of , FDA records hold 6 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- ODW
- Device name
- Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System
- FDA definition
- An in vitro diagnostic assay for use in genotyping Cytochrome P450 2C9 (CYP450 2C9) alleles. Information about the CYP2C9 genotype may be used as an aid to clinicians in determining therapeutic strategy for medications that are metabolized by the CYP2C9 gene product.
- Regulation
- 21 CFR 862.3360
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 6
- Ingested recalls
- 1
Clearances, product code ODW
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2016 | 1 |
| 2019 | 1 |
Applicants with the most clearances
Product code ODW| Applicant | Clearances |
|---|---|
| Akonni Biosystems, Inc. | 1 |
| Autogenomics, Incorporated | 1 |
| Genmark Diagnostics, Incorporated | 1 |
| Luminex Corporation | 1 |
| Osmetech Molecular Diagnostics | 1 |
| Trimgen Corporation | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
